Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date:	January 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$19.43B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.38%
Avg Daily Range (30 D):	$0.43 | 1.77%
Avg Daily Range (90 D):	$0.37 | 1.69%

Institutional Daily Volume
Avg Daily Volume:	3.07M
Avg Daily Volume (30 D):	5.23M
Avg Daily Volume (90 D):	6.07M

Trade Size
Avg Trade Size (Sh.):	146
Avg Trade Size (Sh.) (30 D):	100
Avg Trade Size (Sh.) (90 D):	121

Institutional Trades
Total Institutional Trades:	3,740
Avg Institutional Trade:	$3.86M
Avg Institutional Trade (30 D):	$4.76M
Avg Institutional Trade (90 D):	$5.32M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$10.11M
Avg Closing Trade (30 D):	$25.28M
Avg Closing Trade (90 D):	$24.39M
Avg Closing Volume:	803.17K

News

Feb 13, 2026 @ 8:21 PM Healthcare REIT Posts 16.4% NOI Growth as Shares S... Source: Jonathan Ponciano

Feb 6, 2026 @ 12:00 PM Immunovant Provides Corporate Updates and Reports ... Source: Immunovant, Inc.

Feb 6, 2026 @ 12:00 PM Pulmovant Announces Completion of Enrollment in th... Source: Pulmovant/Roivant

Jan 20, 2026 @ 3:31 PM Sun Pharma Eyes Organon In What Could Be India Pha... Source: Vandana Singh

Dec 18, 2025 @ 7:35 AM Is Immunovant Stock a Buy After Roivant Sciences I... Source: Robert Izquierdo

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-1.17	$-.38	$-.17
Diluted EPS	$-1.17	$-.38	$-.17
Revenue	$13.31M	$2M	$1.57M
Gross Profit
Net Income / Loss	$-1006.03M	$-313.7M	$-166.04M
Operating Income / Loss	$-1215.27M	$-339.15M	$-306.23M
Cost of Revenue
Net Cash Flow	$-514.87M	$241.18M	$-2.66M
PE Ratio